Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept SPECT imaging with 99mTc-Fucoidan in acute deep vein thrombosis
2019-000133-39Phase 2Completed
- Sponsor
- Academic Medical Center
- Start
- May 2019
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gamma Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of technetium Tc 99m fucoidan in deep vein thrombosis (DVT), sponsored by Academic Medical Center. Primary endpoint: Difference in 99mTc-Fucoidan uptake between affected and unaffected veins. Started May 2019; status: completed.
02
Drugs
technetium Tc 99m fucoidan
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on 2019-000133-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000133-39.